SURG: financial statements from SEC — TradeAlmanac

SURG

SurgePays, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	57m	61m
Cost of revenue	68m	75m
Selling, general and administrative	20m	27m
Operating expenses	91m	103m
Operating income	−34m	−42m
Pre-tax income	−36m	−43m
Income tax	—	3m
Net income	−36m	−46m
Earnings per share	−1.80	−2.39
Earnings per share, diluted	−1.80	−2.39
Weighted average shares	20m	19m
Weighted average shares, diluted	20m	19m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Oct 31, 2024	Sep 30, 2024
Cash and equivalents	2m	2m	3m	4m	5m	12m	—	14m
Short-term investments	—

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	−21m	−21m
Depreciation and amortisation	859,970	942,450
Capital expenditure	18,590	518,189
Investing cash flow	−18,590	−3m
Financing cash flow	11m	22m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)